South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
Department of Chemical Pathology, National Health Laboratory Service, Dr. George Mukhari Academic Hospital, Johannesburg, Gauteng, South Africa.
Pan Afr Med J. 2023 Jul 18;45:129. doi: 10.11604/pamj.2023.45.129.39255. eCollection 2023.
coronavirus disease 2019 (SARS-CoV-2), a global pandemic, popularised the term "lockdown" due to its rapid spread around the world. "Lockdown" was used as an emergency measure to temporarily prevent people from entering or leaving their communities in an effort to reduce the spread of the virus. The effects of the "lockdown" measures on the management of chronic medical conditions in African populations have been inconsistent. This study aimed to assess the effects of the lockdown on glycaemic control in patients with diabetes.
retrospective study that examined metadata from 1 January 2019 to 31 December 2021, to assess the impact of the national SARS-CoV-2 response on the quantity and average level of haemoglobin A1c and random glucose in patients with diabetes at Dr. George Mukhari Academic Hospital. The data was retrieved from the National Health Laboratory Services corporate data warehouse.
from 2019 to 2021, a total of 9,039 tests were performed, with females accounting for 63.21% (n = 5,714) and males for 36.08% (n = 3,261), while 0.7% (n = 70) did not have an assigned gender. Mean age was 49, with a standard deviation (SD) of 21.71. The testing rate (TR) in 2019 was 10.74 per day, 2020 had a TR of 6.07, and 2021 had a TR of 7.95. During the pandemic phase, all other age groups had TRs below 1.85, except the 50-59, 60-69, and 70+ year-old groups.
the study revealed that SARS-CoV-2 lockdown measures were linked to poor diabetes control in patients. As a result, the consequences of managing SARS-CoV-2 had a direct influence on diabetes management.
2019 年冠状病毒病（SARS-CoV-2）在全球迅速传播，这一术语“封锁”广为人知。封锁”被用作一项紧急措施，以暂时防止人们进出社区，以减少病毒的传播。封锁措施对非洲人群中慢性疾病管理的影响并不一致。本研究旨在评估封锁对糖尿病患者血糖控制的影响。
本研究回顾性分析了 2019 年 1 月 1 日至 2021 年 12 月 31 日的元数据，以评估国家 SARS-CoV-2 应对措施对 Dr. George Mukhari 学术医院糖尿病患者的血红蛋白 A1c 和随机血糖数量和平均水平的影响。数据从国家卫生实验室服务公司数据仓库中检索。
2019 年至 2021 年共进行了 9039 次检测，女性占 63.21%（n=5714），男性占 36.08%（n=3261），0.7%（n=70）未分配性别。平均年龄为 49 岁，标准差（SD）为 21.71。2019 年检测率（TR）为 10.74 天/人，2020 年 TR 为 6.07，2021 年 TR 为 7.95。在大流行期间，除 50-59、60-69 和 70+岁组外，所有其他年龄组的 TR 均低于 1.85。
本研究表明，SARS-CoV-2 封锁措施与患者糖尿病控制不佳有关。因此，管理 SARS-CoV-2 的后果直接影响了糖尿病的管理。
